New Blog Post:
Generative AI Unlocks Powerful Antibodies Against SARS-CoV-2 and Future Viral Threats
Announcement:
Novartis and Generate:Biomedicines Announce Collaboration
Contact
Curious about our work? Get in touch.
InvestorsJason Silversinvestors@generatebiomedicines.com
Media InquiriesMegan McLaughlinpr@generatebiomedicines.com
Collaboration& PartnershipsSahm Nasseripartner@generatebiomedicines.com